login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
WALDENCAST PLC-A (WALD) Stock News
USA
- NASDAQ:WALD -
JE00BPG99318
-
Common Stock
1.89
USD
+0.11 (+6.18%)
Last: 11/13/2025, 8:03:31 PM
1.89
USD
0 (0%)
After Hours:
11/13/2025, 8:03:31 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
WALD Latest News, Press Relases and Analysis
All
Press Releases
2 days ago - By: Waldencast plc
Waldencast plc Provides Information Regarding Upcoming Earnings Release Dates
2 days ago - By: Waldencast plc
Waldencast plc Provides Information Regarding Upcoming Earnings Release Dates
a month ago - By: Waldencast plc
Obagi Medical Launches Nu-Cil® BioStim™ Scalp Serum
a month ago - By: Waldencast plc
Obagi Medical Launches Nu-Cil® BioStim™ Scalp Serum
4 months ago - By: Croma Pharma
Croma-Pharma GmbH Announces Strategic Milestone as Novaestiq Corp. Joins Waldencast
4 months ago - By: ACCESS Newswire
Gore Range Capital Announces Sale of Novaestiq Corp. to Waldencast
2 months ago - By: Waldencast plc
Waldencast Announces FDA Approval of Obagi® saypha® MagIQ™ Injectable Hyaluronic Acid Gel Under the Obagi Medical Brand
2 months ago - By: Waldencast plc
Waldencast Announces FDA Approval of Obagi® saypha® MagIQ™ Injectable Hyaluronic Acid Gel Under the Obagi Medical Brand
3 months ago - By: Yahoo Finance
Waldencast price target lowered to $3 from $4 at Telsey Advisory
3 months ago - By: Yahoo Finance
- Mentions:
LAZ
Waldencast Delays Earnings Release, Initiates Strategic Review Following Novaestiq Acquisition
3 months ago - By: Benzinga
- Mentions:
ALXO
FLXS
LASE
GTI
...
Why Palo Alto Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
3 months ago - By: Waldencast plc
Waldencast Announces Strong Progress on Business Priorities for H1 2025 and Initiatives to Drive Transformation
3 months ago - By: Waldencast plc
Waldencast Announces Strong Progress on Business Priorities for H1 2025 and Initiatives to Drive Transformation
3 months ago - By: Benzinga
- Mentions:
RSKD
BTDR
API
FFAI
...
Earnings Scheduled For August 18, 2025
3 months ago - By: Yahoo Finance
Waldencast plc (WALD) Acquired Novaestiq Corp. and the US Rights to the Saypha Line of Hyaluronic Acid Injectable Gels
4 months ago - By: Waldencast plc
Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha®, Under the Obagi Medical Brand
4 months ago - By: Waldencast plc
Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha®, Under the Obagi Medical Brand
6 months ago - By: Yahoo Finance
Waldencast price target lowered to $4 from $5 at Telsey Advisory
6 months ago - By: Waldencast plc.
Waldencast Reports Q1 2025 Financial Results
6 months ago - By: Waldencast plc.
Waldencast Reports Q1 2025 Financial Results
6 months ago - By: Waldencast plc.
Waldencast plc Announces First Quarter Fiscal 2025 Results Conference Call and Webcast
6 months ago - By: Waldencast plc.
Waldencast plc Announces First Quarter Fiscal 2025 Results Conference Call and Webcast
7 months ago - By: Waldencast plc.
Obagi Medical Announces the Launch of Retinol + PHA Refining Night Cream
7 months ago - By: Waldencast plc.
Obagi Medical Announces the Launch of Retinol + PHA Refining Night Cream
8 months ago - By: Waldencast plc.
Waldencast Reports Q4 2024 and Fiscal Year 2024 Financial Results
8 months ago - By: Waldencast plc.
Waldencast Reports Q4 2024 and Fiscal Year 2024 Financial Results
8 months ago - By: Waldencast plc.
Waldencast plc Announces Fourth Quarter and Fiscal Year 2024 Results Conference Call and Webcast
8 months ago - By: Waldencast plc.
Waldencast plc Announces Fourth Quarter and Fiscal Year 2024 Results Conference Call and Webcast
9 months ago - By: Waldencast plc.
Waldencast Announces Participation in the TD Cowen 2nd Annual Glowing Ahead: Beauty & Wellness Summit
9 months ago - By: Waldencast plc.
Obagi Medical Announces the Launch of Latest Innovations in The SUZANOBAGIMD® Collection
9 months ago - By: Waldencast plc.
Obagi Medical Announces the Launch of Latest Innovations in The SUZANOBAGIMD® Collection
10 months ago - By: Waldencast plc.
Waldencast plc Announces Upcoming Earnings Release and Conference Call Dates
10 months ago - By: Waldencast plc.
Waldencast plc Announces Upcoming Earnings Release and Conference Call Dates
10 months ago - By: Waldencast plc.
Waldencast Announces Participation in the 2025 IMCAS World Congress
Please enable JavaScript to continue using this application.